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Pharmacogenetics is about how the genetic inheritance of a person
affects his response to medicine, examining relationships between
genes and drug metabolism, drug response and adverse effects.
Despite a reasonably long history of this field, which took off in the
1950s, success stories in cancer pharmacogenetics were rather
lacking, with the most quoted examples being thiopurine
methyltransferase (TPMT) genotype affecting the metabolism of
mercaptopurine, and association between the promoter poly-
morphism in UDP-glucuronosyltransferase 1A1 gene and irinote-
can induced adverse drug reactions.
In the last decade, the generation of a huge amount of genetic
information by the Human Genome Project and the HapMap
project, accompanied by the rapid improvement in genotyping
technologies, have fuelled an increase in genetics studies on the
aetiology of common traits. These same reasons also enable
pharmacogenetic studies to move from mostly single gene based to
genome-wide investigations. Reflecting this gain in scale, the term
‘pharmacogenomics’ is now often used. Together with the
development of targeted cancer therapy with drugs like Glivec
(Imatinib), Iressa (Gefitinib) and Herceptin (Trastuzumab),
pharmacogenomics is set to play a bigger role in both under-
standing cancer drug mechanisms and in clinical practice.
Pharmacogenomics: methods and protocols, is one of the latest
additions to the long running ‘Methods on Molecular Biology’
series. This book aims to introduce the latest technology in
complex genetics to its readers, presumably bench-based scientists
who are interested in recreating the experimental system for
pharmacogenomic studies in their laboratory. The opening chapter
provides a historical overview of the field and is followed by 12
chapters of protocols. The last section deals with the management
of pharmacogenomic information.
The core of this book is the protocols, which are divided into
two groups. The first group contains four chapters on functional
analysis of gene variations, with three of them describing
methodologies in investigating allele specific expression. The
second part covers a range of genotyping techniques, from
fluorescence-based microsatellite typing to SNP typing methods
including pyrosequencing, Taqman and MALDI-TOF (Sequenom).
Each of these chapters begins with an abstract and a brief
introduction explaining the theoretical basis of the system, before
launching into the detailed description of materials and methods.
The protocols are concise and well written – in most cases enough
instructions are provided for the reader to follow the experiment
without the help of supplementary information. Their value,
however, depends largely on the technique being described. The
protocols are most useful for complicated assays like the
Haplotype-specific Chromatin Immunoprecipitation, where multi-
ple molecular biology techniques has to be carried out and the
fine-tuning of experimental parameters vital to eventual success.
Genotyping techniques, on the other hand, are often highly
standardised, and instruction manuals can be obtained from the
company manufacturing the genotyping equipment, making some
of the protocols less interesting.
What distinguishes this book from the standard protocols,
however, is the Notes section of each chapter, where the ‘tricks’ of
the experimental system are discussed. The authors of this book
are leading experts in complex genetics and pharmacogenetics,
and their experience in applying particular techniques is the most
valuable information for the readers. The tips they provided are
very specific and often pinpoint both practical details (down to the
particular type of flask to use) and issues in good experimental
design (e.g. suggesting appropriate controls). By following them
the readers can get a better grasp of the critical steps in the each
procedure and hence have a higher chance of success when setting
them up.
Most of the protocols contain a short description of the expected
output from the experiment, often consists of a figure or a
screenshot. It would be beneficial to expand this section and
include more information on troubleshooting.
I suspect the majority of the readers of Pharmacogenomics:
methods and protocols will only need a few of the protocols
described. In the ideal world a book like this would be helpful
when deciding on the particular technology at the beginning of a
pharmacogenomic study. Practically though, the choice often
depends on the availability of machinery and expertise in the
laboratory rather than any other factor. So all in all, this book is a
fine collection of protocols describing state of the art methods in
functional and complex genetics that can be used in pharmaco-
genomics. While it might not become a most treasured item for
individual scientists, it is certainly a good reference book to have
in one’s institute library.
C Lai
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